Breakthroughs in AI and multi-omics integration are enabling unprecedented accuracy in disease prediction and personalized medicine. A new AI model predicts preterm birth with nearly 90% accuracy by analyzing aggregated omics data. Concurrently, immune profiling techniques are advancing cancer treatment strategies by delineating patient-specific immunological signatures, enhancing responsiveness to therapies. These innovations are shaping precision oncology and maternal-fetal healthcare.